Extracellular domain of human 4-1BBL enhanced T-lymphocyte induced by dendritic cell

被引:8
作者
Wu, Chenxuan [1 ]
Guo, Hongxing [2 ]
Wang, Yijun [1 ]
Gao, Yingtang [1 ]
Zhu, Zhengyan [1 ]
Du, Zhi [1 ]
机构
[1] Tianjin Med Univ, Tianjin Cent Hosp 3, Tianjin Key Lab Artificial Cells, Tianjin 300170, Peoples R China
[2] Chinese Acad Med Sci, Inst Hematol, Tianjin 300020, Peoples R China
关键词
4-1BBL; Costimulation; Cytotoxic T lymphocyte; Dendritic cell; Hepatocellular carcinoma; PHASE-I/II TRIAL; IN-VITRO; HEPATOCELLULAR-CARCINOMA; CANCER PATIENTS; LIGAND; IMMUNOTHERAPY; EXPRESSION; RESPONSES; THERAPY; COSTIMULATION;
D O I
10.1016/j.cellimm.2011.06.013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interaction of costimulatory molecules and their receptors is crucial for tumor lysate-pulsed dendritic cells (sensitized DC, sDC) to promote T cell activation, clonal expansion and its antitumor immunity. To augment the costimulatory signal may regulate the interaction between DC and cytotoxic T lymphocyte (CTL) and consequently enhance the antitumor response. The costimulatory ligand and receptor pair of 4-1BB/4-1BBL is one of the main factors in the costimulation of CTL. We explored the adjuvant role of a recombinant human 4-1BBL extracellular domain (ex4-1BBL) in modulating CTL activation induced by HepG2 antigen-loaded DC (sDC). The augment effects of sDC in combination with ex4-1BBL on the proliferation, activation, cell survival and cytotoxicity against HepG2 cells of CTL were examined. In the presence of ex4-1BBL, sDC exhibited markedly augmented effects on the above four functions of CTL These results demonstrate that ex4-1BBL plays an important role in the costimulation pathway for DC-mediated CTL's activation, which might be a useful adjuvant factor for DC-based cancer biotherapy. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:118 / 123
页数:6
相关论文
共 38 条
  • [1] Aalamian-Matheis M, 2007, ADV EXP MED BIOL, V601, P173
  • [2] MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF HUMAN 4-1BB AND ITS LIGAND
    ALDERSON, MR
    SMITH, CA
    TOUGH, TW
    DAVISSMITH, T
    ARMITAGE, RJ
    FALK, B
    ROUX, E
    BAKER, E
    SUTHERLAND, GR
    DIN, WS
    GOODWIN, RG
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) : 2219 - 2227
  • [3] The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules:: implications for tumor immune escape
    Algarra, I
    García-Lora, A
    Cabrera, T
    Ruiz-Cabello, F
    Garrido, F
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (10) : 904 - 910
  • [4] Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
    Brennan, Frank R.
    Morton, Laura Dill
    Spindeldreher, Sebastian
    Kiessling, Andrea
    Allenspach, Roy
    Hey, Adam
    Muller, Patrick Y.
    Frings, Werner
    Sims, Jennifer
    [J]. MABS, 2010, 2 (03) : 233 - 255
  • [5] A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides
    Butterfield, LH
    Ribas, A
    Dissette, VB
    Lee, Y
    Yang, JQ
    De la Rocha, P
    Duran, SD
    Hernandez, J
    Seja, E
    Potter, DM
    McBride, WH
    Finn, R
    Glaspy, JA
    Economou, JS
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (09) : 2817 - 2825
  • [6] Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
    Butterfield, Lisa H.
    Ribas, Antoni
    Potter, Douglas M.
    Economou, James S.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (12) : 1931 - 1943
  • [7] Role of 4-1BB:4-1BB ligand in cancer immunotherapy
    Cheuk, ATC
    Mufti, GJ
    Guinn, BA
    [J]. CANCER GENE THERAPY, 2004, 11 (03) : 215 - 226
  • [8] Mechanisms involved in synergistic anticancer immunity of Anti-4-1BB and Anti-CD4 therapy
    Choi, Beom K.
    Kim, Young H.
    Kang, Woo J.
    Lee, Sun K.
    Kim, Kwang H.
    Shin, Su M.
    Yokoyama, Wayne M.
    Kim, Tae Y.
    Kwon, Byoung S.
    [J]. CANCER RESEARCH, 2007, 67 (18) : 8891 - 8899
  • [9] 4-1BB Functions As a Survival Factor in Dendritic Cells
    Choi, Beom K.
    Kim, Young H.
    Kwon, Patrick M.
    Lee, Sang C.
    Kang, Sang W.
    Kitu, Moon S.
    Lee, Myoung J.
    Kwon, Byoung S.
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182 (07) : 4107 - 4115
  • [10] Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells
    Futagawa, T
    Akiba, H
    Kodama, T
    Takeda, K
    Hosoda, Y
    Yagita, H
    Okumura, K
    [J]. INTERNATIONAL IMMUNOLOGY, 2002, 14 (03) : 275 - 286